N-(2-((1H-Imidazol-1-yl)methyl)benzyl)-N-(2-oxo-2-((2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)-amino)ethyl)pivalamide

ID: ALA4850583

Chembl Id: CHEMBL4850583

PubChem CID: 142473404

Max Phase: Preclinical

Molecular Formula: C33H34N6O3

Molecular Weight: 562.67

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)C(=O)N(CC(=O)Nc1ccc2c(c1)CC1(C2)C(=O)Nc2ncccc21)Cc1ccccc1Cn1ccnc1

Standard InChI:  InChI=1S/C33H34N6O3/c1-32(2,3)31(42)39(19-24-8-5-4-7-23(24)18-38-14-13-34-21-38)20-28(40)36-26-11-10-22-16-33(17-25(22)15-26)27-9-6-12-35-29(27)37-30(33)41/h4-15,21H,16-20H2,1-3H3,(H,36,40)(H,35,37,41)

Standard InChI Key:  CFLNBARNZDDSHZ-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4850583

    ---

Associated Targets(Human)

ADM2 Tchem ADM2 (28 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CALCB Tclin Calcitonin gene-related peptide 2 (24 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 562.67Molecular Weight (Monoisotopic): 562.2692AlogP: 4.33#Rotatable Bonds: 7
Polar Surface Area: 109.22Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.74CX Basic pKa: 6.47CX LogP: 4.44CX LogD: 4.41
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.35Np Likeness Score: -1.14

References

1. Zirimwabagabo JO, Jailani ABA, Avgoustou P, Tozer MJ, Gibson KR, Glossop PA, Mills JEJ, Porter RA, Blaney P, Wang N, Skerry TM, Richards GO, Harrity JPA..  (2021)  Discovery of a First-In-Class Small Molecule Antagonist against the Adrenomedullin-2 Receptor: Structure-Activity Relationships and Optimization.,  64  (6.0): [PMID:33666424] [10.1021/acs.jmedchem.0c02191]

Source